Professional
Added to YB: 2023-12-18
Pitch date: 2023-12-15
BAX [bullish]
Baxter International Inc.
-42.46%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States.
Market Cap
$10.7B
Pitch Price
$37.09
Price Target
67.00 (+214%)
Dividend
0.19%
EV/EBITDA
8.60
P/E
-11.82
EV/Sales
1.64
Sector
Health Care Equipment and Supplies
Category
value
Show full summary:
Baxter: Shares Look Attractively Valued Considering its Improving Intermediate-Term Outlook
BAX<$67 tgt attractive post-2025 on Kidney Care divestiture+med utilization+inflation easing+contract renegotiations w/ GPOs for pricing. Mkt overreacted to obesity drug impact on dialysis demand. Results hit by inflation+low utilization but relief expected. Moaty portfolio.
Read full article (10 min)